ALBIREO PHARMA, INC. Quarterly Common Stock, Shares Authorized from Q3 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Albireo Pharma, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q3 2010 to Q3 2022.
  • Albireo Pharma, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2022 was 60M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 60M 0 0% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 60M 0 0% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 60M +30M +100% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 60M +30M +100% Dec 31, 2021 10-Q 2022-11-08
Q3 2021 60M +30M +100% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 60M +30M +100% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 30M 0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 30M 0 0% Dec 31, 2020 10-K 2022-03-01
Q3 2020 30M 0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 30M 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 30M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 30M 0 0% Dec 31, 2019 10-K 2021-02-25
Q3 2019 30M 0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 30M 0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 30M 0 0% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 30M 0 0% Dec 31, 2018 10-Q 2019-11-06
Q3 2018 30M 0 0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 30M 0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 30M -170M -85% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 30M -170M -85% Dec 31, 2017 10-K 2019-03-06
Q3 2017 30M -170M -85% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 30M -170M -85% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 200M 0 0% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 200M +200M Dec 31, 2016 10-K 2018-03-27
Q3 2016 200M 0 0% Sep 30, 2016 10-K 2016-12-22
Q2 2016 200M 0 0% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 200M 0 0% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 0 -62.5M -100% Dec 31, 2015 10-K 2017-03-27
Q3 2015 200M 0 0% Sep 30, 2015 10-K 2016-12-22
Q2 2015 200M +138M +220% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 200M +138M +220% Mar 31, 2015 10-Q/A 2015-06-01
Q4 2014 62.5M 0 0% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 200M +138M +220% Sep 30, 2014 10-K 2015-12-22
Q2 2014 62.5M 0 0% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 62.5M 0 0% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 62.5M 0 0% Dec 31, 2013 10-Q 2014-02-10
Q3 2013 62.5M 0 0% Sep 30, 2013 10-K 2014-12-19
Q2 2013 62.5M +37.5M +150% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 62.5M -37.5M -37.5% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 62.5M -37.5M -37.5% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 62.5M +37.5M +150% Sep 30, 2012 10-K 2013-12-20
Q2 2012 25M -75M -75% Jun 30, 2012 10-Q/A 2012-09-12
Q1 2012 100M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 100M Dec 31, 2011 10-Q 2012-02-09
Q3 2011 25M -75M -75% Sep 30, 2011 10-K 2012-12-21
Q2 2011 100M Jun 30, 2011 10-Q 2011-08-09
Q3 2010 100M Sep 30, 2010 10-K 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.